Has Uchechukwu Obih, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,761 in general payments to Uchechukwu Obih, MD across 39 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Uchechukwu Obih, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Uchechukwu Obih, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Uchechukwu Obih, MD

Rheumatology · Seattle, WANPI 1912298860

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,665 of the $2,761 with a category attached, or 60.3%. UCB, Inc. accounts for 60.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $1,949 and has fallen 93.1% since, to $134 in 2023.

$2,761in general payments, 2019–2025

Across 39 payments — averaging $70.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

UCB, Inc.$2K
AbbVie$682
Novartis$186
Amgen$130
Aurinia Pharma U.S., Inc.$98

What the payments were for

Consulting fees$1,66560%
Food & beverage$1,08839%
Education$70%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
UCB, Inc.	1	$1,665
AbbVie	18	$682
Novartis	17	$186
Amgen	2	$130
Aurinia Pharma U.S., Inc.	1	$98

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Rinvoq$125
Skyrizi$113
Tavneos$111
Humira$105

How this compares

$2,761 in reported general payments places this provider in the 70th percentile of 157 rheumatology providers in Washington.

See all rheumatology providers in Washington →

Medicare billing

Part B allowed, 2024

$60,854

Medicare patients

180

Services billed

663

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Enbrel SureclickEtanercept	30	$231,012
Humira(Cf) PenAdalimumab	23	$215,425
Hydroxychloroquine Sulfate	300	$8,109
MethotrexateMethotrexate Sodium	323	$5,393
Mycophenolic AcidMycophenolate Sodium	18	$4,916
Mycophenolate Mofetil	46	$4,705
Colchicine	43	$2,555
Leflunomide	51	$1,884
Prednisone	263	$1,744
Gabapentin	93	$1,594
Febuxostat	18	$1,313
Sulfasalazine	39	$1,172
Tramadol Hcl	73	$770
Ondansetron OdtOndansetron	17	$751
Pregabalin	24	$719

Paid to pharmacies, not to this prescriber.

Other rheumatology in Seattle

Stanford PengSeattle$3.5M
Philip MeaseSeattle$2.1M
Jane BucknerSeattle$57K
Steven OvermanSeattle$17K
Anthony KrajcerSeattle$14K
Amish DaveSeattle$13K
Namrata SinghSeattle$13K
Peter MohaiSeattle$12K
Myriam GuevaraSeattle$12K
Kwang Hoon HanSeattle$11K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →